Loading clinical trials...
Loading clinical trials...
Treatment With Infusional Dose-adjusted Etoposide/Vincristine/Doxorubicin/Bolus Cyclophosphamide/Dexamethasone and Rituximab (DA-EDOCH14-R) in Patients With Poor-prognosis Diffuse Large B-cell Lymphoma
Conditions
Interventions
Dexamethasone and dose-dense immunochemoterapy
Locations
1
Spain
Principe de Asturias University Hospital
Alcalá de Henares, Madrid, Spain
Start Date
December 1, 2009
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2012
Last Updated
February 12, 2010
NCT07397832
NCT06043011
NCT04488354
NCT05583149
NCT02570542
NCT07215832
Lead Sponsor
Hospital Universitario Principe de Asturias
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions